Company Filing History:
Years Active: 2004-2009
Title: Masashi Imanishi: Innovator in Aminoalcohol Derivatives
Introduction
Masashi Imanishi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of aminoalcohol derivatives. With a total of 4 patents to his name, Imanishi's work has implications for the treatment of various medical conditions.
Latest Patents
One of Imanishi's latest patents focuses on aminoalcohol derivatives. The present invention relates to a compound formula [I], wherein the compound [I] and its pharmaceutically acceptable salts are useful for the prophylactic and/or therapeutic treatment of pollakiuria or urinary incontinence. This innovation highlights the potential of his research in addressing important health issues.
Career Highlights
Throughout his career, Masashi Imanishi has worked with prominent companies in the pharmaceutical industry. He has been associated with Astellas Pharma GmbH and Fujisawa Pharmaceutical Company, Ltd. His experience in these organizations has contributed to his expertise and success as an inventor.
Collaborations
Imanishi has collaborated with several professionals in his field. Notable coworkers include Kouji Hattori and Yasuyo Tomishima. These collaborations have likely enriched his research and development efforts.
Conclusion
Masashi Imanishi is a distinguished inventor whose work in aminoalcohol derivatives has the potential to impact medical treatments significantly. His contributions to the pharmaceutical industry are noteworthy and reflect his dedication to innovation.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.